公开(公告)号：US20240351999A1

公开(公告)日：2024-10-24

申请号：US18569148

申请日：2022-06-10

申请人： INSTITUTE OF MATERIA MEDICA ,CHINESE ACADEMY OF MEDICAL SCIENCES

发明人： Song WU ,  Wenxuan ZHANG ,  Xintong ZHAO ,  Qingyun YANG ,  Jing FENG ,  Jie ZHANG ,  Chi ZHANG ,  Zunsheng HAN ,  Tianlei LI ,  Jie XIA ,  Kun ZHANG ,  Bo LIU ,  Huihui SHAO ,  Yue WANG ,  Yuhua HU ,  Xinyu LUO ,  Hanyilan ZHANG ,  Xu LIAN ,  Zihao ZHU

IPC分类号： C07D401/14 ,  A61K31/454 ,  A61K31/497 ,  A61K31/501 ,  A61K31/506 ,  A61K45/06 ,  A61P31/04 ,  C07D413/14 ,  C07D417/14

CPC分类号： C07D401/14 ,  A61K31/454 ,  A61K31/497 ,  A61K31/501 ,  A61K31/506 ,  A61K45/06 ,  A61P31/04 ,  C07D413/14 ,  C07D417/14

摘要： The present invention belongs to the technical field of antibacterial drugs, and discloses a pyrrolylacylpiperidylamine compound and use thereof. The present invention in particular relates to a pyrrolylacylpiperidylamine compound and a pharmaceutically acceptable salt thereof, and use thereof in the preparation of a medicament for resisting infections with bacteria, mycoplasma or chlamydia. The compound has a structure shown in the following general formula: